443 related articles for article (PubMed ID: 28063763)
1. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer.
Qi Q; Geng Y; Sun M; Wang P; Chen Z
Pancreatology; 2015; 15(2):145-50. PubMed ID: 25641673
[TBL] [Abstract][Full Text] [Related]
3. The effect of preoperative neutrophil, platelet and lymphocyte counts on local recurrence and survival in early-stage tongue cancer.
Ozturk K; Akyildiz NS; Uslu M; Gode S; Uluoz U
Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4425-4429. PubMed ID: 27188509
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
[TBL] [Abstract][Full Text] [Related]
5. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer.
Kano S; Homma A; Hatakeyama H; Mizumachi T; Sakashita T; Kakizaki T; Fukuda S
Head Neck; 2017 Feb; 39(2):247-253. PubMed ID: 27617428
[TBL] [Abstract][Full Text] [Related]
7. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.
Lee SM; Russell A; Hellawell G
Korean J Urol; 2015 Nov; 56(11):749-55. PubMed ID: 26568792
[TBL] [Abstract][Full Text] [Related]
9. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
10. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.
Turri-Zanoni M; Salzano G; Lambertoni A; Giovannardi M; Karligkiotis A; Battaglia P; Castelnuovo P
Head Neck; 2017 Apr; 39(4):730-736. PubMed ID: 28032937
[TBL] [Abstract][Full Text] [Related]
12. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
13. The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer.
Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
Int J Colorectal Dis; 2015 Sep; 30(9):1165-71. PubMed ID: 26049902
[TBL] [Abstract][Full Text] [Related]
14. Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
Stotz M; Liegl-Atzwanger B; Posch F; Mrsic E; Thalhammer M; Stojakovic T; Bezan A; Pichler M; Gerger A; Szkandera J
PLoS One; 2016; 11(7):e0159448. PubMed ID: 27454486
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma.
Lu A; Li H; Zheng Y; Tang M; Li J; Wu H; Zhong W; Gao J; Ou N; Cai Y
Biomed Res Int; 2017; 2017():3047802. PubMed ID: 28321405
[TBL] [Abstract][Full Text] [Related]
16. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.
Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H
Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.
Sierzega M; Lenart M; Rutkowska M; Surman M; Mytar B; Matyja A; Siedlar M; Kulig J
Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341
[TBL] [Abstract][Full Text] [Related]
18. What can preoperative blood tests tell us about colorectal cancer?
Kostakis ID; Vaiopoulos AG; Garoufalia Z; Papavassiliou AG; Kykalos S; Kouraklis G; Tsourouflis G
J BUON; 2018 Dec; 23(7):84-95. PubMed ID: 30722116
[TBL] [Abstract][Full Text] [Related]
19. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
[TBL] [Abstract][Full Text] [Related]
20. Platelet to lymphocyte ratio and red cell distribution width as prognostic factors for survival and recurrence in patients with oral cancer.
Tangthongkum M; Tiyanuchit S; Kirtsreesakul V; Supanimitjaroenporn P; Sinkitjaroenchai W
Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3985-3992. PubMed ID: 28866825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]